Saturday, March 10, 2012

Lit Bits: March 10, 2012

From the recent medical literature...

1. Association of Age and Sex with CP-free AMI and In-Hospital Mortality

Canto JG, et al. JAMA 2012;307(8):813-822.

Context Women are generally older than men at hospitalization for myocardial infarction (MI) and also present less frequently with chest pain/discomfort. However, few studies have taken age into account when examining sex differences in clinical presentation and mortality.

Objective To examine the relationship between sex and symptom presentation and between sex, symptom presentation, and hospital mortality, before and after accounting for age in patients hospitalized with MI.

Design, Setting, and Patients Observational study from the National Registry of Myocardial Infarction, 1994-2006, of 1 143 513 registry patients (481 581 women and 661 932 men).

Main Outcome Measures We examined predictors of MI presentation without chest pain and the relationship between age, sex, and hospital mortality.

Results The proportion of MI patients who presented without chest pain was significantly higher for women than men (42.0% [95% CI, 41.8%-42.1%] vs 30.7% [95% CI, 30.6%-30.8%]; P less than .001). There was a significant interaction between age and sex with chest pain at presentation, with a larger sex difference in younger than older patients, which became attenuated with advancing age. Multivariable adjusted age-specific odds ratios (ORs) for lack of chest pain for women (referent, men) were younger than 45 years, 1.30 (95% CI, 1.23-1.36); 45 to 54 years, 1.26 (95% CI, 1.22-1.30); 55 to 64 years, 1.24 (95% CI, 1.21-1.27); 65 to 74 years, 1.13 (95% CI, 1.11-1.15); and 75 years or older, 1.03 (95% CI, 1.02-1.04). Two-way interaction (sex and age) on MI presentation without chest pain was significant (P less than .001). The in-hospital mortality rate was 14.6% for women and 10.3% for men. Younger women presenting without chest pain had greater hospital mortality than younger men without chest pain, and these sex differences decreased or even reversed with advancing age, with adjusted OR for age younger than 45 years, 1.18 (95% CI, 1.00-1.39); 45 to 54 years, 1.13 (95% CI, 1.02-1.26); 55 to 64 years, 1.02 (95% CI, 0.96-1.09); 65 to 74 years, 0.91 (95% CI, 0.88-0.95); and 75 years or older, 0.81 (95% CI, 0.79-0.83). The 3-way interaction (sex, age, and chest pain) on mortality was significant (P less than .001).

Conclusion In this registry of patients hospitalized with MI, women were more likely than men to present without chest pain and had higher mortality than men within the same age group, but sex differences in clinical presentation without chest pain and in mortality were attenuated with increasing age.

2. Septic Shock? Reach for Norepinephrine After Fluid Resuscitation

A meta-analysis shows that dopamine is associated with increased risk for death and arrhythmic events compared with norepinephrine.

Although current guidelines recommend either dopamine or norepinephrine as the vasopressors of choice for septic shock, a recent meta-analysis of six interventional studies suggested that norepinephrine is the superior agent (JW Emerg Med Apr 22 2011). Investigators conducted a meta-analysis of the same six interventional studies — excluding patients with nonseptic shock — and five observational studies; the analysis involved a total of 2768 adult patients.

Observational studies showed significant heterogeneity in results overall and no difference in mortality between patients treated with dopamine and those treated with norepinephrine. After exclusion of one trial that accounted for the heterogeneity, dopamine was associated with an increased risk for death at 28 days over norepinephrine (relative risk, 1.23). Interventional trials were homogeneous and likewise showed a significantly increased risk for death with dopamine use (RR, 1.12). Two interventional studies that reported arrhythmic events showed a significant increase in these events in the dopamine groups (RR, 2.34).

An editorialist suggests that dopamine, a more powerful β-agonist than norepinephrine, could still be considered in patients with septic shock, hypotension (systolic blood pressure below 90 mm Hg), and either a low cardiac index (below 2.5 L/minute/m2) or low heart rate (below 90 beats per minute).

Comment: This study supports norepinephrine as the vasopressor of choice for adult patients with septic shock. Dopamine is relegated to a secondary role, perhaps to be used when cardiac output is insufficient despite optimal use of norepinephrine.

— Kristi L. Koenig, MD, FACEP. Published in Journal Watch Emergency Medicine March 2, 2012. Citation: De Backer D et al. Dopamine versus norepinephrine in the treatment of septic shock: A meta-analysis. Crit Care Med 2012 Mar; 40:725.

3. Patients Often Use ED Even When Primary Care Is Available

Lasker KE. Emergency department use by primary care patients at a safety-net hospital. Arch Int Med. 2012;172:278-280.

Larry Hand. Medscape Medical News. February 14, 2012 — As national healthcare reform proceeds, hospitals that have benefited financially from high use of emergency departments (EDs) by routine primary care patients will be challenged to retool primary care delivery and payment methods, according to a research letter published in the February 13 issue of the Archives of Internal Medicine.

Karen E. Lasker, MD, MPH, from the Section of General Internal Medicine, Department of Medicine, Boston Medical Center (BMC) and Boston University School of Medicine, and the Department of Community Health Sciences, Boston University School of Public Health, in Massachusetts, and colleagues analyzed the use of ED services by established primary care patients at BMC, a safety-net hospital, between July 1, 2009, and July 1, 2010. They found that about half of all ED primary care visits took place during weekdays when primary care practices were open and seeing patients.

BMC has 8 primary care practices employing 105 primary care physicians (PCPs). During the study period, a total of 39,603 patients had 1 or more primary care visits to BMC. Of those, 65.4% did not visit the ED during the study period; however, 29.8% visited the ED 1 to 3 times and 4.9% visited the ED 4 or more times. Overall the 11,787 patients in the intermediate-use group made 17,759 visits and the 1928 patients in the frequent-use group made 12,289 visits.

The researchers estimate that most ED visits were for low-severity services, based on an analysis of International Classification of Diseases, Ninth Revision, Clinical Modification, codes.

Dr. Lasker and colleagues cited the lack of available PCP appointments as a possible reason for the ED visits during weekdays. At the same time, the practices experienced almost a 25% rate of missed appointments, which often correlates with long wait times for schedule appointments.

"It is possible that patients called the practices with an urgent problem, did not have their telephone call answered promptly, and decided to seek care in the ED instead," the authors write. Patients abandoned about 13% of their calls to the PCP offices during the study period.

Another possible factor in the use of ED services for low-severity needs is that about a fifth of the primary care services are provided by residents who have limited availability because of hospital requirements.

"Massachusetts has been a bellwether for the implementation of health reform and will be a bellwether for the transformation of primary care, with the move away from fee-for-service payments and the introduction of global payments for health care," the authors write. In that regard, they note, as Massachusetts health reform has led to more newly insured patients getting primary care services in large numbers, "it is possible that access to primary care has worsened for other patients."

Whether changes in practice and payment will reduce high ED usage in this way is unclear, they conclude.

The study was supported by the Department of Medicine at Boston Medical Center/Boston University School of Medicine. Dr. Lasker has disclosed that she was a consultant to Rise Health in 2011.

4. Prediction of haematoma growth and outcome in patients with ICH using the CT-angiography spot sign (PREDICT): a prospective observational study

Demchuk AM, et al. The Lancet Neurology, Early Online Publication, 8 March 2012

Background: In patients with intracerebral haemorrhage (ICH), early haemorrhage expansion affects clinical outcome. Haemostatic treatment reduces haematoma expansion, but fails to improve clinical outcomes in many patients. Proper selection of patients at high risk for haematoma expansion seems crucial to improve outcomes. In this study, we aimed to prospectively validate the CT-angiography (CTA) spot sign for prediction of haematoma expansion.

Methods: PREDICT (predicting haematoma growth and outcome in intracerebral haemorrhage using contrast bolus CT) was a multicentre prospective observational cohort study. We recruited patients aged 18 years or older, with ICH smaller than 100 mL, and presenting at less than 6 h from symptom onset. Using two independent core laboratories, one neuroradiologist determined CTA spot-sign status, whereas another neurologist masked for clinical outcomes and imaging measured haematoma volumes by computerised planimetry. The primary outcome was haematoma expansion defined as absolute growth greater than 6 mL or a relative growth of more than 33% from initial CT to follow-up CT. We reported data using standard descriptive statistics stratified by the CTA spot sign. Mortality was assessed with Kaplan-Meier survival analysis.

Findings: We enrolled 268 patients. Median time from symptom onset to baseline CT was 135 min (range 22—470), and time from onset to CTA was 159 min (32—475). 81 (30%) patients were spot-sign positive. The primary analysis included 228 patients, who had a follow-up CT before surgery or death. Median baseline ICH volume was 19•9 mL (1•5—80•9) in spot-sign-positive patients versus 10•0 mL (0•1—102•7) in spot-sign negative patients (p less than 0•001). Median ICH expansion was 8•6 mL (−9•3 to 121•7) for spot-sign positive patients and 0•4 mL (−11•7 to 98•3) for spot-negative patients (p less than 0•001). In those with haematoma expansion, the positive predictive value for the spot sign was 73%; the negative predictive value was 84%, sensitivity was 63%, and specificity was 90%. Median 3-month modified Rankin Scale (mRS) was 5 in CTA spot-sign-positive patients, and 3 in spot-sign-negative patients (p less than 0•001). Mortality at 3 months was 43•4% (23 of 53) in CTA spot-sign positive versus 19•6% (31 of 158) in CTA spot-sign-negative patients (HR 2•4, 95% CI 1•4—4•0, p=0•002).

Interpretation: These findings confirm previous single-centre studies showing that the CTA spot sign is a predictor of haematoma expansion. The spot sign is recommended as an entry criterion for future trials of haemostatic therapy in patients with acute ICH.

5. Pilot Study Suggests that Tenecteplase Might Edge t-PA in Acute Stroke

By: Mitchell Zoler, Elsevier Global Medical News. 03/08/12

NEW ORLEANS – The potential advantages of tenecteplase, a modified form of tissue plasminogen activator engineered to outperform the native molecule, finally shone through for treating patients with acute, ischemic stroke.

A head-to-head comparison of tenecteplase against recombinant tissue plasminogen activator (t-PA; alteplase) showed that the modified molecule produced better reperfusion and better clinical recovery 24 hours after treatment in a randomized trial of 75 Australian patients whose treatment was guided by CT brain imaging, Dr. Bill O’Brien reported at the International Stroke Conference.

Although Dr. O’Brien cautioned that this pilot study did not produce definitive results, the superiority of tenecteplase eclipsed its failure to surpass t-PA in a randomized comparison of 112 patients reported in 2010.

The results "support using advanced imaging to identify the patients who are most likely to benefit" from tenecteplase, he said. The use of systematic CT brain imaging to select patients appeared to be the main factor that distinguished this study from the previous trial where tenecteplase failed to show an advantage, said Dr. O’Brien, a stroke physician at John Hunter Hospital in Newcastle, Australia.

Targeted patient selection may also explain why the tenecteplase treatment was so safe, resulting in a trend toward a reduced rate of type 2 parenchymal hemorrhages, compared with t-PA, despite the superior thrombolytic activity shown by tenecteplase, he said.

Although the current trial had "compelling results," another study will follow to compare the two drugs by several 3-month outcomes, Dr. O’Brien said in an interview. The successful dosages of tenecteplase tested also have the advantage of being cheaper than the standard t-PA dosage, he added.

Developed in the 1990s, tenecteplase resulted from three targeted amino acid substitutions in conventional t-PA. This produced a molecule with increased fibrin specificity, and longer plasma half-life due to increased resistance to enzymatic degradation, which meant that it could be administered by an intravenous bolus instead of requiring continuous infusion like t-PA. When used to treat myocardial infarctions, tenecteplase has also resulted in fewer bleeding complications than t-PA.

The study enrolled 75 patients within 6 hours of onset of an ischemic stroke at any of three Australian hospitals, following selection by CT imaging to identify patients with a small infarct core and a large penumbra of salvageable brain. Researchers randomized patients to receive 0.1 mg/kg tenecteplase or 0.25 mg/kg tenecteplase by an intravenous bolus injection, or standard infusion with 0.9 mg/kg t-PA. The patients averaged 70 years old, their average NIHSS (National Institutes of Health Stroke Scale) score at entry was about 14, and patients received treatment an average of about 3 hours after symptom onset.

The reperfusion rate after 24 hours was 78% among all 50 patients treated with tenecteplase, and 55% among the t-PA treated patients, a statistically significant difference for one of the study’s two primary end points, Dr. O’Brien said. The second primary end point, change in NIHSS score after 24 hours, improved by an average of 8 points in all 50 tenecteplase patients, and by an average of 3 points in the t-PA patients, also a significant difference.

The results appeared to show a dose-response relationship for tenecteplase, with the 25 patients who received the 0.25-mg/kg dosage having better reperfusion rates and reductions in their NIHSS scores than the 25 patients who received a 0.1-mg/kg dosage as well as the patients treated with t-PA, but Dr. O’Brien did not report specific numbers from this analysis.

Of the 50 tenecteplase patients, 2 (4%) developed a type 2 parenchymal hemorrhage within 24 hours, compared with 4 (16%) of the 25 t-PA-treated patients, a difference that trended toward significance. The rates of symptomatic intracerebral hemorrhages and death at 24 hours were similar with both drugs. But at 90 days after treatment, the combined rate of death or severe disability was 10% in the 50 tenecteplase patients and 25% in the t-PA patients, a difference that also trended toward significance.

These findings contrast with a 2010 report from a randomized trial that compared three different tenecteplase dosages with t-PA in a multicenter U.S. study of 112 patients (Stroke 2010;41:707-11). The results showed no significant differences between any of the tenecteplase dosages and t-PA for any of the outcomes measured out to 90 days after treatment.

The major difference between the U.S. study and the new Australian study was in patient selection, Dr. O’Brien said. "We used imaging to balance the groups," and to select patients who stood to benefit most from effective reperfusion, he said.

Dr. O’Brien said that he and his associates had no disclosures.

6. Proxies Put Rosy Tint on Grim Prognoses

By Crystal Phend, Senior Staff Writer, MedPage Today. March 08, 2012

Surrogate decision makers readily accepted good news about critically-ill patients, but showed an optimistic bias when it came to a poor prognosis, researchers found.

Surrogates' interpretation of a 90% chance of surviving was accurate without much variation, according to an ICU-based study by Douglas B. White, MD, of the University of Pittsburgh Medical Center, and colleagues.

But when the surrogates heard "5% chance of survival," the interpretation was a median 15% chance of survival and above 40% in a quarter of cases (P less than 0.001 for difference), the group reported in the March 6 issue of the Annals of Internal Medicine.

The presumption is often that discordance on prognosis is because physicians aren't being clear or surrogates simply misunderstand, they noted.

However, interviews with the surrogates pointed to two main reasons for the inaccurate interpretations:
Need for hope in the face of a poor prognosis
Belief that the patient has attributes unknown to the physician

Clinicians need to be aware of these biases, which likely impact decisions on life support, the researchers noted.

"Interventions to improve this element of decision making will probably require attention not only to the clarity with which risk information is conveyed but also to the emotional and psychological factors that affect how individuals process such information," White's group recommended.

They conducted an experiment with 80 surrogates of critically-ill patients at three ICUs at San Francisco hospitals, asking them to interpret various prognostic statements hypothetically rather than as part of clinical conversations with the patient's physician.

The questionnaire asked randomly ordered questions, such as "If a doctor says 'He will definitely survive,' what does that mean to you?" Participants could answer in five-percentage point increments on a probability scale from "Will not survive (0% chance of survival)" to "Will survive (100% chance of survival)."

When asked to interpret a 90% chance of survival, 60% put down down the correct answer (median 90%, P=0.11).

The opposite was true when interpreting a 5% chance of survival, with 65% rating the chances of survival as higher than 5% (median 15%, P less than 0.001).

Interpretations of a 50% chance of survival fell in the middle, with 40% answering more optimistically than warranted by the statement.

Interviews with fifteen of the surrogates whose answers were overly optimistic suggested that they often weren't aware of their bias (seven of 15).

Explanations given by the surrogates for their optimistic reinterpretation of the prognostic statements included:

"I always hope for the best outcome for my husband. Even with [a] five percent chance of survival there is still hope."

"I do think that a person's will to live and their ability to survive very stressful situations can have an impact on whether they are going to survive or not."

"I don't give a lot of weight to the individual number. I tend not to trust the individual number as much as the overall feeling that [the physician] is conveying. When [the physician] says 90%, I'm not thinking 9 out [of] 10, I'm thinking that [the physician] is very confident but not entirely sure."

Skepticism in the accuracy of predictions of death isn't necessarily irrational, White's group noted.

But optimism isn't always ethically benign, they added.

"For example, if self-protection makes a surrogate emotionally unable to acknowledge when a patient has a very poor prognosis," the investigators wrote, "the surrogate may request ongoing use of life support when the patient's values suggest that a transition to comfort measures only is more appropriate."

The group cautioned that their hypothetical results "may not fully replicate the circumstances and emotional responses that arise in actual clinician–family encounters."

Zier LS, et al "Surrogate decision makers' interpretation of prognostic information: a mixed-methods study" Ann Intern Med 2012; 156: 360-366.

http://www.annals.org/content/156/5/360.abstract

7. CPR: Pump Hard, Fast, and Deep

Most patients in this large study received chest compressions at depths less than the recommended amount.

Recent emphasis on the quality of cardiopulmonary resuscitation (CPR) and concern about chest compressions being too slow and too shallow have prompted real-time measurement. Researchers analyzed electronic CPR compression depth data from the Resuscitation Outcomes Consortium for a convenience sample of 1029 adult patients treated by 58 emergency medical services (EMS) agencies in seven U.S. and Canadian cities from 2006 to 2009. Patients with EMS-witnessed arrest and those who received bystander defibrillation were excluded.

Overall, median compression rate was 106 per minute, and median compression depth was 37.3 mm. About half of patients (53%) had a recorded compression depth less than 38 mm, and nearly all (92%) had depths less than 50 mm. Faster compression rates correlated with smaller compression depths. In a univariate comparison of characteristics of the 50 patients who survived to hospital discharge with those of patients who did not survive, outcomes were better when compression depth was greater than 38 mm.

Comment: The recommended depth for CPR is at least 50 mm (and was 38–50 mm at the time of the study). The results of this study are dismal, showing that depth of compression was inadequate for most patients. We need to ensure proper feedback-facilitated training along with performance measurement for quality improvement. If we do not train adequately and measure performance, we cannot improve clinical outcomes.

— Kristi L. Koenig, MD, FACEP. Published in Journal Watch Emergency Medicine March 9, 2012. Citation: Stiell IG et al. What is the role of chest compression depth during out-of-hospital cardiac arrest resuscitation? Crit Care Med 2012 Jan 5; [e-pub ahead of print].

8. Do Physicians Understand Cancer Screening Statistics? A National Survey of Primary Care Physicians in the United States

Wegwarth O, et al. Ann Intern Med. 2012;156:340-349 .

Background: Unlike reduced mortality rates, improved survival rates and increased early detection do not prove that cancer screening tests save lives. Nevertheless, these 2 statistics are often used to promote screening.

Objective: To learn whether primary care physicians understand which statistics provide evidence about whether screening saves lives.

Design: Parallel-group, randomized trial (randomization controlled for order effect only), conducted by Internet survey. (ClinicalTrials.gov registration number: NCT00981019)

Setting: National sample of U.S. primary care physicians from a research panel maintained by Harris Interactive (79% cooperation rate).

Participants: 297 physicians who practiced both inpatient and outpatient medicine were surveyed in 2010, and 115 physicians who practiced exclusively outpatient medicine were surveyed in 2011.

Intervention: Physicians received scenarios about the effect of 2 hypothetical screening tests: The effect was described as improved 5-year survival and increased early detection in one scenario and as decreased cancer mortality and increased incidence in the other.

Measurements: Physicians' recommendation of screening and perception of its benefit in the scenarios and general knowledge of screening statistics.

Results: Primary care physicians were more enthusiastic about the screening test supported by irrelevant evidence (5-year survival increased from 68% to 99%) than about the test supported by relevant evidence (cancer mortality reduced from 2 to 1.6 in 1000 persons). When presented with irrelevant evidence, 69% of physicians recommended the test, compared with 23% when presented with relevant evidence (P less than 0.001). When asked general knowledge questions about screening statistics, many physicians did not distinguish between irrelevant and relevant screening evidence; 76% versus 81%, respectively, stated that each of these statistics proves that screening saves lives (P = 0.39). About one half (47%) of the physicians incorrectly said that finding more cases of cancer in screened as opposed to unscreened populations “proves that screening saves lives.”

Limitation: Physicians' recommendations for screening were based on hypothetical scenarios, not actual practice.

Conclusion: Most primary care physicians mistakenly interpreted improved survival and increased detection with screening as evidence that screening saves lives. Few correctly recognized that only reduced mortality in a randomized trial constitutes evidence of the benefit of screening.

9. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial

Kobayashi T, et al. The Lancet, Early Online Publication, 8 March 2012

Background: Evidence indicates that corticosteroid therapy might be beneficial for the primary treatment of severe Kawasaki disease. We assessed whether addition of prednisolone to intravenous immunoglobulin with aspirin would reduce the incidence of coronary artery abnormalities in patients with severe Kawasaki disease.

Methods: We did a multicentre, prospective, randomised, open-label, blinded-endpoints trial at 74 hospitals in Japan between Sept 29, 2008, and Dec 2, 2010. Patients with severe Kawasaki disease were randomly assigned by a minimisation method to receive either intravenous immunoglobulin (2 g/kg for 24 h and aspirin 30 mg/kg per day) or intravenous immunoglobulin plus prednisolone (the same intravenous immunoglobulin regimen as the intravenous immunoglobulin group plus prednisolone 2 mg/kg per day given over 15 days after concentrations of C-reactive protein normalised). Patients and treating physicians were unmasked to group allocation. The primary endpoint was incidence of coronary artery abnormalities during the study period. Analysis was by intention to treat. This trial is registered with the University Hospital Medical Information Network clinical trials registry, number UMIN000000940.

Findings: We randomly assigned 125 patients to the intravenous immunoglobulin plus prednisolone group and 123 to the intravenous immunoglobulin group. Incidence of coronary artery abnormalities was significantly lower in the intravenous immunoglobulin plus prednisolone group than in the intravenous immunoglobulin group during the study period (four patients [3%] vs 28 patients [23%]; risk difference 0•20, 95% CI 0•12—0•28, p less than 0•0001). Serious adverse events were similar between both groups: two patients had high total cholesterol and one neutropenia in the intravenous immunoglobulin plus prednisolone group, and one had high total cholesterol and another non-occlusive thrombus in the intravenous immunoglobulin group.

Interpretation: Addition of prednisolone to the standard regimen of intravenous immunoglobulin improves coronary artery outcomes in patients with severe Kawasaki disease in Japan. Further study of intensified primary treatment for this disease in a mixed ethnic population is warranted.

10. Greet and Street: Streamlining the ED or Taking Risks?

Shaw, Gina. Emergency Medicine News: March 2012 - Volume 34 - Issue 3 - pp 1,22

Sometimes a headache is just a headache. But sometimes it's a subarachnoid hemorrhage.

The triage process in the emergency department is meant to distinguish between such cases and prioritize the most critical patients. At Halifax Health System in Daytona Beach, FL, a new cost-saving policy aimed at reducing unnecessary ED use has recently raised the stakes for accurate triage.

Beginning in mid-May, all patients 18 to 64 deemed not to be emergencies are directed to an on-site health clinic charging $48 per visit or are given a list of community resources. If they really want to be seen in the emergency department, they can pay their insurance co-pay or $350 in cash up front.

Director of Emergency Services Peter Springer, MD, explained that likely nonemergent cases are identified by chief complaint, for which they did a literature review to establish categories, such as chronic tooth and ear pain, sore throats and minor cold and flu symptoms, suture removals, hemorrhoids and constipation, and nonacute psychiatric presentations. Patients are given a quick, focused physical by a physician or physician assistant. “If it really is a nonemergent case, we give them some choices,” he said.

Halifax is not alone in this policy, which some have dubbed “greet and street.” Those who swear by it say it's EMTALA-compliant: as long as every patient seeking emergency care is given a screening exam, EMTALA doesn't mandate that the hospital has any further obligations if that exam does not reveal an emergent medical condition. Indeed, Central Florida Regional Hospital in nearby Sanford implemented a similar rule to little fanfare a couple of years ago. Like many hospitals, Halifax is facing budget constraints, and notes that about a third of its bad debt is generated by its emergency departments.

“We're trying to appropriately utilize our resources so we have the capacity to effectively treat the true emergencies,” Dr. Springer said.

But what are the risks of such a strict triage policy? And will it really cut costs?

Timothy Platts-Mills, MD, an assistant professor of emergency medicine at the University of North Carolina School of Medicine, has written about ED crowding and the accuracy of triage. He noted that Halifax's exclusion of very young and elderly patients from the new approach mitigates some of the hazards. “In a study we conducted of older adult triage, we found that for roughly a quarter of patients who required an immediate intervention, the need for an immediate intervention was not identified at the time of triage,” he said. “Older adults are more likely to have life-threatening illness or injury, and identifying emergencies in older adults is probably more difficult. To the extent that these providers feel the need to have a policy of diverting nonurgent patients, I think these age limit exclusions make sense.”

The question remains if the rest of patients presenting to the ED — the 18- to 64-year-olds — can be triaged safely to an outpatient setting. “The answer depends on a number of things, including the characteristics of the triage process and the capacity of the outpatient clinic to provide care and recognize when a mis-triage has occurred,” Dr. Platts-Mills said. “If practitioners have limited time to complete triage assessments or if they face external pressure to triage patients into a nonurgent category, I think there is risk to patients. No one is perfect. A triage system that uses a chief complaint alone to identify nonurgent patients would almost certainly be unsafe because for almost any complaint [including common, seemingly mundane complaints such as back pain or dental pain], there will be some patients with that complaint who have a life-threatening condition.”

The essay continues here: http://journals.lww.com/em-news/Fulltext/2012/03000/Breaking_News__Greet_and_Street__Streamlining_the.3.aspx

11. Cardioversion of acute AF in the ED: a prospective randomised trial.

Shocking more effective than propafenone (89% vs 74%) and required a much shorter LOS

Bellone A, et al. Emerg Med J. 2012;29:188-191

Background: Strategies to restore sinus rhythm in patients with atrial fibrillation (AF) lasting less than 48h with haemodynamic stability remain controversial. The aim of this study was to test the hypothesis that electrical cardioversion (EC) would be more effective and safer in converting acute AF to sinus rhythm, compared with intravenous propafenone treatment.

Methods: In the emergency department (ED) of Valduce Hospital, a single-centre randomised trial was conducted to compare EC with pharmacological cardioversion (PC) to restore the sinus rhythm in selected patients with acute AF. A total of 247 patients was enrolled (121 in the EC group and 126 in the PC group). Results EC was more successful than PC in restoring sinus rhythm. Successful cardioversion was achieved in 108 out of 121 patients in the EC group (89.3%) and 93 out of 126 patients in the PC group (73.8%) (HR in the EC group, 0.34; 95% CI 0.17 to 0.68; p=0.02). The time patients spent in the ED undergoing treatment was significantly lower in the EC group compared with the PC group (median (range), 180 (120-900) vs 420 (120-1400) min; p less than 0.001).

Conclusions: EC was more effective in patients with acute AF and resulted in a shorter length of stay in the ED than PC. Adverse events were small in number and transient in both groups of patients.

12. Assessment of Medicare's (Unreliable) Imaging Efficiency Measure for Emergency Department Patients with Atraumatic Headache

Schuur JD, et al. Ann Emerg Med 2012; in press

Study objective: Computed tomography (CT) use has increased rapidly, raising concerns about radiation exposure and cost. The Centers for Medicare & Medicaid Services (CMS) developed an imaging efficiency measure (Outpatient Measure 15 [OP-15]) to evaluate the use of brain CT in the emergency department (ED) for atraumatic headache. We aim to determine the reliability, validity, and accuracy of OP-15.

Methods: This was a retrospective record review at 21 US EDs. We identified 769 patient visits that CMS labeled as including an inappropriate brain CT to identify clinical indications for CT and reviewed the 748 visits with available records. The primary outcome was the reliability of OP-15 as determined by CMS from administrative data compared with medical record review. Secondary outcomes were the measure's validity and accuracy. Outcome measures were defined according to the testing protocol of the American Medical Association's Physician Consortium for Performance Improvement.

Results: On record review, 489 of 748 ED brain CTs identified as inappropriate by CMS had a measure exclusion documented that was not identified by administrative data; the measure was 34.6% reliable (95% confidence interval [CI] 31.2% to 38.0%). Among the 259 patient visits without measure exclusions documented in the record, the measure's validity was 47.5% (95% CI 41.4% to 53.6%), according to a consensus list of indications for brain CT. Overall, 623 of the 748 ED visits had either a measure exclusion or a consensus indication for CT; the measure's accuracy was 16.7% (95% CI 14% to 19.4%). Hospital performance as reported by CMS did not correlate with the proportion of CTs with a documented clinical indication (r=–0.11; P=.63).

Conclusion: The CMS imaging efficiency measure for brain CTs (OP-15) is not reliable, valid, or accurate and may produce misleading information about hospital ED performance.

13. Premature Documentation of Poor Prognosis in Postarrest Therapeutic Hypothermia

In a small study, 21% of patients with factors indicating poor prognosis during postarrest therapeutic hypothermia made full neurological recovery.

Perman SM et al. Crit Care Med 2012 Mar; 40:719
.
OBJECTIVE: Early assessment of neurologic recovery is often challenging in survivors of cardiac arrest. Further, little is known about when to assess neurologic status in comatose, postarrest patients receiving therapeutic hypothermia. We sought to evaluate timing of prognostication in cardiac arrest survivors who received therapeutic hypothermia.

DESIGN: A retrospective chart review of consecutive postarrest patients receiving therapeutic hypothermia (protocol: 24-hr maintenance at target temperature followed by rewarming over 8 hrs). Data were abstracted from the medical chart, including documentation during the first 96 hrs post arrest of "poor" prognosis, diagnostic tests for neuroprognostication, consultations used for determination of prognosis, and outcome at discharge.

SETTING: Two academic urban emergency departments.

PATIENTS: A total of 55 consecutive patients who underwent therapeutic hypothermia were reviewed between September 2005 and April 2009.

INTERVENTION: None.

RESULTS: Of our cohort of comatose postarrest patients, 59% (29 of 49) were male, and the mean age was 56 ± 16 yrs. Chart documentation of "poor" or "grave" prognosis occurred "early": during induction, maintenance of cooling, rewarming, or within 15 hrs after normothermia in 57% (28 of 49) of cases. Of patients with early documentation of poor prognosis, 25% (seven of 28) had care withdrawn within 72 hrs post arrest, and 21% (six of 28) survived to discharge with favorable neurologic recovery. In the first 96 hrs post arrest: 88% (43 of 49) of patients received a head computed tomography, 90% (44 of 49) received electroencephalography, 2% (one of 49) received somatosensory evoked potential testing, and 71% (35 of 49) received neurology consultation.

CONCLUSIONS: Documentation of "poor prognosis" occurred during therapeutic hypothermia in more than half of patients in our cohort. Premature documentation of poor prognosis may contribute to early decisions to withdraw care. Future guidelines should address when to best prognosticate in postarrest patients receiving therapeutic hypothermia.

14. Outcomes of Pregnancies with ED-documented IUPs

A. Fetal loss in symptomatic first-trimester pregnancy with documented yolk sac intrauterine pregnancy

Hessert MJ, et al. Amer J Emerg Med. 2012;30:399-404.

Background: The possibility of spontaneous miscarriage is a common concern among pregnant women in the emergency department (ED).

Objective: This study sought to determine fetal outcomes for women following ED evaluation for first-trimester abdominopelvic pain or vaginal bleeding who had an intrauterine pregnancy (IUP) on ultrasound before a visible fetal pole (“yolk sac IUP”).

Methods: A retrospective chart review of consecutive ED charts from December 2005 to September 2006 identified patients with a yolk sac IUP. Demographic data, obstetric/gynecologic history, and presenting symptoms were obtained. Outcomes were determined via computerized records. Fetal loss was diagnosed by falling β-human chorionic gonadotropin or pathology specimen. Live birth was diagnosed by viable fetus at 20-week ultrasound or delivery.

Results: A total of 131 patients were enrolled in this study. Of these, 14 were lost to follow-up (12%), leaving 117 patient encounters. Of the 117 women, 82 carried their pregnancies to at least 20-week gestation. Thirty-five patients miscarried. Fetal loss rate by chief complaint were as follows: 8 of 46 patients presenting with pain only, 14 of 34 presenting with vaginal bleeding only, and 13 of 37 with both vaginal bleeding and pain.

Conclusion: Seventy percent of women diagnosed with a yolk sac IUP in the ED carried their pregnancy to at least 20 weeks. The remaining women (30%) experienced fetal loss. Vaginal bleeding (with or without pain) increased the rate of fetal loss compared with women with pain only. These data will assist the emergency physician in counseling women with symptomatic first-trimester pregnancies.

B. Prospective outcomes of pregnant ED patients with documented fetal cardiac activity on ultrasound

Mallin M, et al. Amer J Emerg Med. 2012;30:472-475.

Background: Evaluation of rates of spontaneous abortion (SAB) may aid in counseling pregnant patients seen in the emergency department (ED). A recent chart review reported an SAB rate of 10% among ED patients with a documented intrauterine pregnancy (IUP) and cardiac activity on ultrasound. We sought to prospectively evaluate outcomes among pregnant ED patients with documented cardiac activity on ultrasound.

Methods: We prospectively enrolled a convenience sample of pregnant patients presenting to the University of Utah ED between January 1, 2008, and April 30, 2009. Ultrasound was performed during the ED visit. Patient outcomes were followed up 30 days after the ED visit. Patients were contacted by telephone or the medical record was reviewed for documentation of pregnancy status.

Results: Seventy-one patients with an IUP and documented fetal cardiac activity were enrolled. We were able to obtain 30-day follow-up information on 61 patients (85.9%). Average patient age was 26.7 years (range, 17-42 years), average reported gravida was 3.3 (range, 1-8), and average gestational age was 10 weeks. Nine patients (14.8%; 95% confidence interval, 8.7%-23.9%) either reported or had a documented SAB during the 30 days after the ED visit.

Conclusion: In this study, which represents the first prospective evaluation of ED patients with documented IUP with fetal heart tones, the rate of SAB was consistent with that reported previously for this population. These results confirm that ED patients represent a high-risk group, and additional research is needed to better characterize risk factors for SAB.

15. Early vs. Late Treatment of Acute Migraine Attacks

An open-label study in daily neurological practice confirms that migraine attacks should be treated early.

Lantéri-Minet M, et al. Cephalalgia. 2012 Feb;32(3):226-35.

Aim: To compare the effectiveness of early or late triptan intake in the treatment of acute migraine attacks.

Methods: The TEMPO study was a French prospective, multicentre, two-phase study conducted in neurological practice. Two-hundred-and-ten migraine patients who were regular triptan users were enrolled. In the first phase, patients treated three attacks as they usually did. In the second phase, those who initially practiced late dosing ( ≥ 1 hour after headache onset) were instructed to change to early dosing (within 1 hour).

Results: A total of 144 patients completed the first phase. Seventy-nine patients constituted the 'early dosers' group and 65 patients the 'late dosers' group. In this phase, early dosing produced higher rates (n = 38; 52.8%) of freedom from pain at 2 hours in at least two of three attacks compared with late dosing (n = 19; 30.2%; p  less than  0.01). In the second phase, switching from late to early dosing following the physician's instruction (n = 42 patients) also improved the rates of freedom from pain at 2 hours (from 38.1% (n = 16) to 53.7% (n = 22); p  less than  0.05).

Conclusion: This suggests that advising patients on the importance of early triptan intake after headache onset may help improve the efficacy of acute migraine treatments..

16. The Problem with Pradaxa

by Kevin Klauer, DO, EJD. Emergency Physicians Monthly, March 6, 2012.

The FDA-approved drug dabigatran is being marketed as a safe alternative to Coumadin. But without a proven reversal agent available, it has the potential to create a new set of complications, and send unsuspecting patients right back to the ED.

A 77-year-old patient presented to the ED a few months ago after gently falling over onto a carpeted floor while using his walker. The patient appeared well with the exception of dry mucous membranes. He complained of his typical back pain (upper, mid-thoracic) and he reported decreased P.O. intake. His initial blood pressure was 76/48. With no other physical findings, serial fluid boluses were ordered to address the potential of dehydration as the cause of his hypotension and subsequent fall. A further diagnostic evaluation was taken while the fluids were being administered. Sure enough, his urinalysis showed positive nitrate with greater than 100 WBCs. In addition, his BUN and creatinine were 56 and 3.1, respectively. These changes were new. His WBC count was 10.2, Hgb was 11.0, and he was afebrile. Before you ask, his ECG showed an AV-sequential pacemaker without any changes from previous.

So, we had a clinically dehydrated 77-year-old patient with new onset renal failure, most likely secondary to his dehydration associated with his UTI and poor P.O. intake. With a negative review of systems and relatively negative exam, his hypotension fit the picture. However, after two 500cc fluid boluses, his blood pressure hadn’t changed. In a non-septic patient with dehydration, an improvement was expected. However, when the square peg didn’t fit the round hole, it was time to broaden the differential diagnosis. Again, he was asked about his history: “Any new medications? Are you sure this is the same pain you always have? Are you on any blood thinners?” He replied, “Nope. Exactly the same, I used to be on Coumadin but my doctor took me off of that a month ago.” Although this patient’s pain was typical for him, a CT of the chest was ordered.

The CT revealed a pericardial effusion that was further confirmed as cardiac tamponade by bedside 2-D echo, following a call from Radiology reporting a pericardial effusion. The Echo confirmed early tamponade. Now there seemed to be an explanation.

Superimposing tamponade on dehydration likely limited the physical findings of tamponade to refractory hypotension. But what was the cause of the tamponade? On further more insistence history, it turned out the patient was on Pradaxa and Plavix. But now we had a relatively bare cabinet of antidotes. As a result, he received FFP and vitamin K and an emergent pericardial window evacuation of 1000 cc of blood from his acute hemopericardium.

With its narrow therapeutic window, ugly side-effect profile and need for drug monitoring, Coumadin leaves much to be desired, and many physicians have looked forward to a “white knight” drug to take its place. But be careful what you wish for. If you are too needy and too desperate, as we all have been to avoid the use of Coumadin, we may be enticed into early adoption of an alternative that may actually be worse. (I may have been an early adopter of parachute pants in the 80s, but I learned my lesson.) The combination of Coumadin’s drawbacks and the ramped up marketing efforts for Pradaxa has resulted in skyrocketing use of the new drug.

As bad as Coumadin can be, it is inexpensive – less than $0.50 a pill – and its shortcomings are very well known. On the other hand, a daily course of Pradaxa (150 mg BID) will cost over $8. But I certainly wouldn’t advocate the continued use of Coumadin from a cost perspective. If we have something safer, the higher cost is money well spent. The point, however, is that dabigatran’s safety is truly debatable, despite the fact that it was approved by the FDA. (There have been a laundry list of bad actors pulled from the market for safety reasons, despite the FDA’s willingness to approve them.)

At an EM conference in February attended by many international physicians, I asked the participants, “Has anyone seen any complications from Pradaxa yet?” I expected just a few, but I was amazed to see almost half of the audience raise their hands. Despite the fact that no case reports have yet been published, it appears, anecdotally, that real safety issues do exist.

The rest of the essay can be found here: http://www.epmonthly.com/features/current-features/the-problem-with-pradaxa/

17. Incidence of Immediate Hypersensitivity Reaction and Serum Sickness Following Administration of Crotalidae Polyvalent Immune Fab Antivenom: A Meta-analysis

Schaeffer TH, et al. Acad Emerg Med 2012;19:121-131.

Objectives:  Crotalidae polyvalent immune Fab (ovine) (FabAV) is commonly used in the treatment of symptomatic North American crotaline snake envenomation. When approved by the U.S. Food and Drug Administration in 2000, the incidences of immediate hypersensitivity reactions and serum sickness were reported as 0.14 and 0.18, respectively. The objective of this meta-analysis was to evaluate the incidence of immediate hypersensitivity reactions and serum sickness reported in studies of patients treated with FabAV therapy after North American crotaline envenomation.

Methods:  The authors searched PubMed, Ovid MEDLINE, and EMBASE from January 1, 1997, to September 20, 2010, for English-language medical literature and cross-referenced bibliographies of reviewed articles. The published abstracts of the major toxicology conferences were also searched. All prospective and retrospective cohort studies with patients receiving FabAV therapy for North American crotaline envenomations were eligible for data abstraction. Two content experts reviewed full-text articles and extracted relevant study design and outcome data. Proportions of immediate hypersensitivity and serum sickness for each study were analyzed in a random-effects model to produce an overall estimate of immediate hypersensitivity and serum sickness incidence associated with FabAV administration.

Results:  The literature search revealed 11 unique studies of patients who received FabAV that contained information on immediate hypersensitivity reactions and serum sickness. The meta-analysis produced a combined estimate of the incidence of immediate hypersensitivity of 0.08 (95% confidence interval [CI] = 0.05 to 0.11) and a combined estimate of the incidence of serum sickness of 0.13 (95% CI = 0.07 to 0.21).

Conclusions:  In this systematic literature review and meta-analysis, the combined estimates of the incidence of immediate hypersensitivity reactions and serum sickness from FabAV in the treatment of symptomatic North American crotaline envenomations appear to be lower than previously reported, at 0.08 and 0.13, respectively.

18. Predicting outcome of IV thrombolysis-treated ischemic stroke patients: The DRAGON score.

Strbian D, et al. Neurology. 2012 Feb 7;78(6):427-32.

OBJECTIVE: To develop a functional outcome prediction score, based on immediate pretreatment parameters, in ischemic stroke patients receiving IV alteplase.

METHODS: The derivation cohort consists of 1,319 ischemic stroke patients treated with IV alteplase at the Helsinki University Central Hospital, Helsinki, Finland. We evaluated the predictive value of parameters associated with the 3-month outcome and developed the score according to the magnitude of logistic regression coefficients. We assessed accuracy of the model with bootstrapping. External validation was performed in a cohort of 330 patients treated at the University Hospital Basel, Basel, Switzerland. We assessed the score performance with area under the receiver operating characteristic curve (AUC-ROC).

RESULTS: The DRAGON score (0-10 points) consists of (hyper)Dense cerebral artery sign/early infarct signs on admission CT scan (both = 2, either = 1, none = 0), prestroke modified Rankin Scale (mRS) score above 1 (yes = 1), Age (80 years or older = 2, 65-79 years = 1, less than 65 years = 0), Glucose level at baseline (greater than 8 mmol/L [144 mg/dL] = 1), Onset-to-treatment time (over 90 minutes = 1), and baseline National Institutes of Health Stroke Scale score (above 15 = 3, 10-15 = 2, 5-9 = 1, 0-4 = 0). AUC-ROC was 0.84 (0.80-0.87) in the derivation cohort and 0.80 (0.74-0.86) in the validation cohort. Proportions of patients with good outcome (mRS score 0-2) were 96%, 88%, 74%, and 0% for 0-1, 2, 3, and 8-10 points, respectively. Proportions of patients with miserable outcome (mRS score 5-6) were 0%, 2%, 5%, 70%, and 100% for 0-1, 2, 3, 8, and 9-10 points, respectively. External validation showed similar results.

CONCLUSIONS: The DRAGON score is valid at our site and was reliable externally. It can support clinical decision-making, especially when invasive add-on strategies are considered. The score was not studied in patients with basilar artery occlusion. Further external validation is warranted.

19. Pediatric Pain from Fractures Is Undertreated in the ED

Only 70% of children with isolated long bone fractures received pain medication during their emergency department stays.

Dong L, et al. Pediatr Emerg Care 2012 Feb;28(2):109-14.

OBJECTIVES: The objective of the study was to describe analgesia utilization before and during the emergency department (ED) visit and assess factors associated with analgesia use in pediatric patients with isolated long-bone fractures.

METHODS: This retrospective cohort study of patients aged 0 to 15 years with a diagnosis of an isolated long-bone fracture was conducted at a single, level I pediatric trauma center. Patients included were treated in the ED within 12 hours of injury and subsequently admitted to the hospital from January 2005 through August 2007. Pain medication received within the first hour after ED arrival was categorized based on prespecified standard doses as follows: adequate, inadequate, and no pain medication received. Cumulative logistic regression analysis assessed factors associated with analgesia use.

RESULTS: There were 773 patients with isolated long-bone fracture included in the analysis. Overall, 10% of patients received adequate pain medicine; 31% received inadequate medicine; and 59% received no pain medicine within 1 hour of ED arrival. In multivariable analysis, children with younger age, longer time from injury to ED arrival, closed fractures, and upper-extremity fractures were less likely to receive adequate pain medicine during the ED visit. Of those transported by emergency medical services directly from the scene to the ED, 9 (10%) of 88 were given pain medication during transport.

CONCLUSIONS: Pain management in pediatric patients following a traumatic injury has been recognized as an important component of care. This study suggests that alleviation of pain after traumatic injury requires further attention in both the prehospital and ED settings, especially among the youngest children.
.
20. The Emergency Airway: The Best Airway Articles of 2011

Braude, Darren MD, EMT-P. Emergency Medicine News: March 2012 - Volume 34 - Issue 3 - p 10

It is time again to review the most interesting airway literature from this past year, one that gave us some impressive research that every emergency physician should read.

Full-text here: http://journals.lww.com/em-news/Fulltext/2012/03000/The_Emergency_Airway__The_Best_Airway_Articles_of.7.aspx

21. Beam me up Scotty! Impact of personal wireless communication devices in the ED

Richards JD, Harris T. Emerg Med J. 2011 Jan;28(1):29-32.

OBJECTIVE: A qualitative study performed with a cross-sectional survey to report staff perceptions on emergency department (ED) communication while trialling a personal hands-free wireless communication device (WCD) between August and October 2008 in a busy inner city ED.

METHOD: A survey of all Royal London Hospital ED staff was conducted pre and post-implementation of a personal WCD. The survey included responses to occupation, experience, communication modes, communication wait times, perceived interruptions at the bedside and general perceptions of communication efficiency.

RESULTS: No appreciable change in communication modes or perceived waiting times was reported No increase in bedside interruptions were reported. An overwhelming number of respondents considered the system had contributed significantly to improving the quality of the work environment, patient safety and care.

CONCLUSION: This study correlated with others showing a very strong perception of improved communication and working environment: less noise, better handovers and improved staff resource use. The study adds to the limited number of published trials examining WCD in health care. Observational reports post-implementation were overwhelmingly positive. Quantitative studies measuring the impact on patient flow, safety and cost benefits should be considered.

Tuesday, February 21, 2012

Lit Bits: Feb 21, 2012

From the recent medical literature...

1. Fleet Enemas: Causing More than Loose Stools

Fatalities and Severe Metabolic Disorders Associated With the Use of Sodium Phosphate Enemas: A Single Center's Experience

Ori Y, et al. Arch Intern Med. 2012;172(3):263-265.

We report our experience with severe complications of sodium phosphate enemas.

Eleven elderly patients received Fleet enemas for constipation. Three patients received 500 to 798 mL, and 8 received a standard 250-mL dose. Most presented within 24 hours with hypotension and volume depletion, extreme hyperphosphatemia (phosphorus level, 5.3-45.0 mg/dL), and severe hypocalcemia (calcium level, 2.0-8.7 mg/dL). Hypernatremia and hypokalemia were seen in most patients. Acute renal failure was present in all patients. Two patients required urgent hemodialysis. Five patients died (45%). One patient was autopsied. Calcium-phosphate deposition within the renal tubular lumens was found.

Following an educational campaign, the use of Fleet enemas was reduced in our hospital by 96%. Sodium phosphate enemas, even in standard doses, may lead to severe metabolic disorders associated with a high mortality and morbidity. Their use should be limited to low-risk patients only.

2. ED Neurologic Deterioration in Patients with Spontaneous Intracerebral Hemorrhage: Incidence, Predictors, and Prognostic Significance

Fan, J.-S., et al. Acad Emerg Med. 2012;19:133-138.

Objectives:  The objective was to explore the incidence, predictors, and prognostic significance of emergency department (ED) neurologic deterioration in patients with spontaneous intracerebral hemorrhage (SICH).

Methods:  This was a retrospective cohort study conducted at the ED, neurocritical care unit, and general intensive care unit of a university-affiliated medical center. Consecutive adult SICH patients treated in our ED from January 2002 through December 2009 were included, identified from the registered stroke data bank. These were cross-checked for coding with International Classification of Diseases, Ninth Revision, Clinical Modification 431 and 432.9. Enrolled patients had SICH with elapsed times of less than 12 hours and Glasgow Coma Scale (GCS) scores ≥ 13 on arrival. ED neurologic deterioration was defined as having a two-or-more-point decrease in consciousness noted in any GCS score assessment between ED presentation and admission. Comparisons of numerical data were performed using an unpaired t-test (parametric data) or Mann-Whitney U-test (nonparametric data). Comparisons of categorical data were done by chi-square tests. Variables with p below 0.1 in univariate analysis were further analyzed using multiple logistic regression. No variable automated or manual selection methods were used.

Results:  Among the 619 patients with SICH included in the study, 22.6% had ED neurologic deterioration. Independent predictors for ED neurologic deterioration included regular antiplatelet use, ictus to ED arrival time under 3 hours, initial body temperature ≥ 37.5°C, intraparenchymal hemorrhage associated with intraventricular hemorrhage (IVH), and presence of a midline shift of greater than 2 mm on computed tomography (CT). ED neurologic deterioration was associated with 1-week mortality, 30-day mortality, and poor neurologic outcome on discharge.

Conclusions:  Nearly one-quarter of SICH patients with an initial GCS of 13 to 15 had a two points or more deterioration of their GCS while in the ED. ED neurologic deterioration was associated with death and poor neurologic outcomes on discharge. Several risk factors that are available early in the patients’ courses appear to be associated with ED neurologic deterioration. By identifying patients at risk for early neurologic decline and intervening early, physicians may be able to improve patient outcomes.

3. Cardiac Telemetry Identifies A Fib in Cryptogenic Stroke

Caroline Helwick. Medscape Medical News. February 2, 2012 (New Orleans, Louisiana) — Outpatient cardiac telemetry over 21 days detects occult paroxysmal atrial fibrillation (PAF) in almost 20% of patients with cryptogenic cerebral ischemia, a new study shows.

Investigators from Henry Ford Hospital in Detroit, Michigan, reported their results here at the American Stroke Association’s International Stroke Conference 2012.

In one third of patients discharged with stroke or transient ischemic attack (TIA), the etiology of the event remains undetermined, the researchers note. While PAF is known to be a possible cause, factors predicting PAF have not been defined.

"Potentially, 1 in 3 stroke patients could be monitored with this technology," said lead author Daniel J. Miller, MD, at a press briefing. "The reason it is important to identify PAF is that it may change treatment." He explained that standard antiplatelet treatment would not be sufficient for this population, who would benefit instead from anticoagulation. Monitoring for 21 days detected PAF in 17%

Investigators hypothesized that mobile cardiac outpatient telemetry (MCOT), if continued for 21 days, would detect a high rate of PAF and that risk factors could be identified for predicting PAF.

The study was a retrospective analysis on 156 patients (mean age, 68.5 years) evaluated by MCOT monitoring within 6 months of a cryptogenic stroke or TIA. Almost all (97%) were not taking anticoagulation medication and 51% were not taking rate control medication.

Half the patients were women and half were African American; 79% of the index events were stroke, and 35% of patients had a history of prior stroke or TIA, with strokes being fairly mild (National Institutes of Health [NIH] Stroke Scale, 3.0). Hypertension was present in 87% but heart failure was seen in only 8%, Dr. Miller noted.

A multivariate analysis with survival regression analysis was performed using demographic, clinical, neuroimaging, and cardiac imaging characteristics to determine predictive risk factors for the detection of PAF on MCOT.

Twenty-seven of the patients (17.3%) were found to have PAF on monitoring. Two thirds of the episodes lasted less than 30 seconds; 26% lasted more than 30 seconds, and 7.5% of episodes were persistent, he reported.

The study also showed that as the duration of monitoring increased, so did the rate of detection of PAF.

PAF detection significantly increased from 3.8% in the initial 48 hours, to 9.2% at 7 days, to 15.1% at 14 days, and to 19.5% by 21 days (P less than .05).

"MCOT is a robust diagnostic tool for the identification of PAF in patients with cryptogenic stroke and TIA," Dr. Miller said. "Length of monitoring is strongly associated with the likelihood of detection of the condition."

In a multivariate Cox regression analysis, the strongest predictors of PAF were premature atrial complexes (PAC) on electrocardiography and female sex. Other significant factors were increase by 1 cm in left atrial diameter, decrease by 10% in left ventricular ejection fraction, and increase by 1 point in NIH Stroke Scale.

The study received no outside funding. CardioNet provided monitoring results and records at no charge. Dr. Miller and Dr. Biller have disclosed no relevant financial relationships.

International Stroke Conference (ISC) 2012: Abstract 150. Presented February 2, 2012.

4. Hypotension is Uncommon in Patients Presenting to the ED with Non-traumatic Cardiac Tamponade

Kapoor T, et al. J Emerg Med. 2012;42:220-226.

Background: Cardiac tamponade is a life-threatening disease in which hypotension is believed to be a common finding. Prior inpatient studies have described normotensive or hypertensive cases of tamponade; however, because the data were not collected from the Emergency Department (ED), the hemodynamic spectrum may differ from those presenting to the ED.

Objectives: We hypothesized that hypotension is uncommon in patients presenting to the ED with non-traumatic tamponade.

Methods: A retrospective chart review was conducted between January 2002 and December 2007 of patients presenting to our ED who were subsequently diagnosed with cardiac tamponade.

Results: A total of 34 patients were identified with a diagnosis of tamponade. The mean blood pressure on ED arrival was 131/79mm Hg. Upon initial presentation to the ED, 35% (n=12) of patients were hypertensive, 50% (n=17) were normotensive, and 15% (n=5) were hypotensive. Of the 5 patients who were hypotensive on ED arrival, only 2 (6% of all patients) remained hypotensive upon admission to the hospital and before a pericardiocentesis. An average of 995mL of fluid was removed from the pericardium. The chief complaint for the majority of patients in tamponade was shortness of breath (70%); 59% were tachycardic in the ED, and 72% had cardiomegaly on chest X-ray study.

Conclusions: Hypotension is uncommon in patients presenting to the ED with non-traumatic cardiac tamponade. The majority of patients are normotensive or even hypertensive. Thus, the emergency physician should not exclude the diagnosis of tamponade even in light of normotension or hypertension.

5. Preoxygenation and Prevention of Desaturation During Emergency Airway Management

Weingart SD, et al. Ann Emerg Med 2012;59: 165-175.e1

Patients requiring emergency airway management are at great risk of hypoxemic hypoxia because of primary lung pathology, high metabolic demands, anemia, insufficient respiratory drive, and inability to protect their airway against aspiration. Tracheal intubation is often required before the complete information needed to assess the risk of periprocedural hypoxia is acquired, such as an arterial blood gas level, hemoglobin value, or even a chest radiograph.

This article reviews preoxygenation and peri-intubation oxygenation techniques to minimize the risk of critical hypoxia and introduces a risk-stratification approach to emergency tracheal intubation. Techniques reviewed include positioning, preoxygenation and denitrogenation, positive end expiratory pressure devices, and passive apneic oxygenation.

Full-text (free): http://www.annemergmed.com/article/S0196-0644(11)01667-2/fulltext

6. The iScore predicts poor functional outcomes early after hospitalization for an acute ischemic stroke.

Saposnik G, et al. Stroke. 2011 Dec;42(12):3421-8.

BACKGROUND AND PURPOSE: The iScore is a prediction tool originally developed to estimate the risk of death after hospitalization for an acute ischemic stroke. Our objective was to determine whether the iScore could also predict poor functional outcomes.

METHODS: We applied the iScore to patients presenting with an acute ischemic stroke at multiple hospitals in Ontario, Canada, between 2003 and 2008, who had been identified from the Registry of the Canadian Stroke Network regional stroke center database (n=3818) and from an external data set, the Registry of the Canadian Stroke Network Ontario Stroke Audit (n=4635). Patients were excluded if they were included in the sample used to develop and validate the initial iScore. Poor functional outcomes were defined as: (1) death at 30 days or disability at discharge, in which disability was defined as having a modified Rankin Scale 3 to 5; and (2) death at 30 days or institutionalization at discharge.

RESULTS: The prevalence of poor functional outcomes in the Registry of the Canadian Stroke Network and the Ontario Stroke Audit, respectively, were 55.7% and 44.1% for death at 30 days or disability at discharge and 16.9% and 16.2%, respectively, for death at 30 days or institutionalization at discharge. The iScore stratified the risk of poor outcomes in low- and high-risk individuals. Observed versus predicted outcomes showed high correlations: 0.988 and 0.940 for mortality or disability and 0.985 and 0.993 for mortality or institutionalization in the Registry of the Canadian Stroke Network and Ontario Stroke Audit cohorts.

CONCLUSIONS: The iScore can be used to estimate the risk of death or a poor functional outcome after an acute ischemic stroke.

7. GlideScope Versus Flexible Fiber Optic for Awake Upright Laryngoscopy

Silverton NA, et al. Ann Emerg Med. 2011;59:159-164.

Study objectives: We compare laryngoscopic quality and time to highest-grade view between a face-to-face approach with the GlideScope and traditional flexible fiber-optic laryngoscopy in awake, upright volunteers.

Methods: This was a prospective, randomized, crossover study in which we performed awake laryngoscopy under local anesthesia on 23 healthy volunteers, using both a GlideScope video laryngoscopy face-to-face technique with the blade held upside down and flexible fiber-optic laryngoscopy. Operator reports of Cormack-Lehane laryngoscopic views and video-reviewed time to highest-grade view, as well as number of attempts, were recorded.

Results: Ten women and 13 men participated. A grade II or better view was obtained with GlideScope video laryngoscopy in 22 of 23 (95.6%) participants and in 23 of 23 (100%) participants with flexible fiber-optic laryngoscopy (relative risk GlideScope video laryngoscopy versus flexible fiber-optic laryngoscopy 0.96; 95% confidence interval 0.88 to 1.04). Median time to highest-grade view for GlideScope video laryngoscopy was 16 seconds (interquartile range 9 to 34) versus 51 seconds (interquartile range 35 to 96) for flexible fiber-optic laryngoscopy. A distribution of interindividual differences demonstrated that GlideScope video laryngoscopy was, on average, 39 seconds faster than flexible fiber-optic laryngoscopy (95% confidence interval 0.2 to 76.9 seconds).

Conclusion: GlideScope video laryngoscopy can be used to obtain a Cormack-Lehane grade II or better view in the majority of awake, healthy volunteers when an upright face-to-face approach is used and was slightly faster than traditional flexible fiber-optic laryngoscopy. However, flexible fiber-optic laryngoscopy may be more reliable at obtaining high-grade views of the larynx. Awake, face-to-face GlideScope use may offer an alternative approach to the difficulty airway, particularly among providers uncomfortable with flexible fiber-optic laryngoscopy.

8. Comparison of Role of Early (Less Than Six Hours) to Later (More Than Six Hours) or No Cardiac Catheterization after Resuscitation From Out-of-Hospital Cardiac Arrest

Strote JA, et a. Amer J Cardiol. 2012;109:451-454.
.
Despite reports of patients with resuscitated sudden cardiac arrest (rSCA) receiving acute cardiac catheterization, the efficacy of this strategy is largely unknown. We hypothesized that acute cardiac catheterization of patients with rSCA would improve survival to hospital discharge.

A retrospective cohort of 240 patients with out-of-hospital rSCA caused by ventricular tachycardia or fibrillation was identified from 11 institutions in Seattle, Washington from 1999 through 2002. Patients were grouped into those receiving acute catheterization within 6 hours (≤6-hour group, n = 61) and those with deferred catheterization beyond 6 hours or no catheterization during the index hospitalization (beyond 6-hour group, n = 179). Attention was directed to survival to hospital discharge, neurologic status, extent of coronary artery disease, presenting electrocardiographic findings, and symptoms before arrest. Propensity-score methods were used to adjust for the likelihood of receiving acute catheterization.

Survival was greater in patients who underwent acute catheterization (72% in the ≤6-hour group vs 49% in the beyond 6-hour group, p = 0.001). Percutaneous coronary intervention was performed in 38 of 61 patients (62%) in the ≤6-hour group and 13 of 170 patients (7%) in the beyond 6-hour group (p less than 0.0001). Neurologic status was similar in the 2 groups. A significantly larger percentage of patients in the acute catheterization group had symptoms before cardiac arrest and had ST-segment elevation on electrocardiogram after resuscitation.

Age, bystander cardiopulmonary resuscitation, daytime presentation, history of percutaneous coronary intervention or stroke, and acute ST-segment elevation were positively associated with receiving cardiac catheterization. In conclusion, in this series of patients who sustained out-of-hospital cardiac arrest, acute catheterization (less than 6 hours of presentation) was associated with improved survival.

9. Rapid Sequence Intubation from the Patient's Perspective

Kimball D, et al. West J Emerg Med. 2011 Nov;12(4):365-7.

INTRODUCTION: This study assesses the efficacy of the rapid sequence intubation (RSI) protocol in preventing patient recollection of resuscitative events and patient discomfort during intubation, as subjectively determined by the patient.

METHODS: This was a prospective study of all patients intubated at Los Angeles County, University of Southern California Medical Center from July 2009 to January 2010. Extubated patients were interviewed using a standard questionnaire and data collection tool.

RESULTS: Of 211 airway codes, 201 were excluded due to death before extubation, transfer, or persistent vegetative state, leaving 10 awake, alert subjects who were interviewed regarding their recollection of the RSI and resuscitation. Five had recollection of the event. Most patients recalling RSI described the event as painful or uncomfortable despite receiving the recommended doses of sedation/induction agents.

CONCLUSION: In this cohort of 10 patients intubated using typical agents, 5 remembered some details of their intubation and 2 described pain that was 10/10 on a verbal pain scale. Further work is indicated to ensure that the medications used during this procedure provide the appropriate sedation and amnesia.

Full-text (free): http://www.escholarship.org/uc/item/3wg7h4rg

10. The Medial-Transverse Approach for IJ Vein Cannulation: An Example of Lateral Thinking

Ho AM, et al. J Emerg Med. 2012;42:174-177.

Background: Cannulation of the internal jugular vein (IJV) is traditionally performed using the central-longitudinal approach. Pneumothorax, carotid artery puncture, and failure to cannulate are uncommon, but by no means rare, complications. Ultrasound (US) guidance for IJV cannulation has reduced but not eliminated such complications.

Technique: We herein introduce a new approach, coined the “medial-transverse approach” due to the perpendicular angle at which the introducer needle is advanced toward the IJV from the median to lateral direction.

Discussion: The direction of the introducer needle is not toward the lung, thus virtually eliminating the possibility of pneumothorax. The image of the entire needle is seen when the US probe is typically orientated for a short-axis view of the IJV and carotid artery, thus improving the chance of uncomplicated IJV puncture. We have used this technique with apparent success in thousands of cases over the past 20 years in two different institutions.

Conclusion: A modified IJV cannulation technique that seems to have unique advantages over traditional approaches has been described. This technique is compatible with the blind and US-guided approaches.

11. Intramuscular versus Intravenous Therapy for Prehospital Status Epilepticus

Silbergleit R, et al. for the NETT Investigators. N Engl J Med 2012; 366:591-600.

Background: Early termination of prolonged seizures with intravenous administration of benzodiazepines improves outcomes. For faster and more reliable administration, paramedics increasingly use an intramuscular route.

Methods: This double-blind, randomized, noninferiority trial compared the efficacy of intramuscular midazolam with that of intravenous lorazepam for children and adults in status epilepticus treated by paramedics. Subjects whose convulsions had persisted for more than 5 minutes and who were still convulsing after paramedics arrived were given the study medication by either intramuscular autoinjector or intravenous infusion. The primary outcome was absence of seizures at the time of arrival in the emergency department without the need for rescue therapy. Secondary outcomes included endotracheal intubation, recurrent seizures, and timing of treatment relative to the cessation of convulsive seizures. This trial tested the hypothesis that intramuscular midazolam was noninferior to intravenous lorazepam by a margin of 10 percentage points.

Results: At the time of arrival in the emergency department, seizures were absent without rescue therapy in 329 of 448 subjects (73.4%) in the intramuscular-midazolam group and in 282 of 445 (63.4%) in the intravenous-lorazepam group (absolute difference, 10 percentage points; 95% confidence interval, 4.0 to 16.1; P less than 0.001 for both noninferiority and superiority). The two treatment groups were similar with respect to need for endotracheal intubation (14.1% of subjects with intramuscular midazolam and 14.4% with intravenous lorazepam) and recurrence of seizures (11.4% and 10.6%, respectively). Among subjects whose seizures ceased before arrival in the emergency department, the median times to active treatment were 1.2 minutes in the intramuscular-midazolam group and 4.8 minutes in the intravenous-lorazepam group, with corresponding median times from active treatment to cessation of convulsions of 3.3 minutes and 1.6 minutes. Adverse-event rates were similar in the two groups.

Conclusions: For subjects in status epilepticus, intramuscular midazolam is at least as safe and effective as intravenous lorazepam for prehospital seizure cessation. (Funded by the National Institute of Neurological Disorders and Stroke and others; ClinicalTrials.gov number, ClinicalTrials.gov NCT00809146.)

12. Amoxicillin for Acute Rhinosinusitis: As Good as Placebo—but More Expensive

A Randomized Controlled Trial

Garbutt JM, et al. JAMA 2012; 307(7):685-692.

Context Evidence to support antibiotic treatment for acute rhinosinusitis is limited, yet antibiotics are commonly used.

Objective To determine the incremental effect of amoxicillin treatment over symptomatic treatments for adults with clinically diagnosed acute rhinosinusitis.

Design, Setting, and Participants A randomized, placebo-controlled trial of adults with uncomplicated, acute rhinosinusitis were recruited from 10 community practices in Missouri between November 1, 2006, and May 1, 2009.

Interventions Ten-day course of either amoxicillin (1500 mg/d) or placebo administered in 3 doses per day. All patients received a 5- to 7-day supply of symptomatic treatments for pain, fever, cough, and nasal congestion to use as needed.

Main Outcome Measures The primary outcome was improvement in disease-specific quality of life after 3 to 4 days of treatment assessed with the Sinonasal Outcome Test-16 (minimally important difference of 0.5 units on a 0-3 scale). Secondary outcomes included the patient's retrospective assessment of change in sinus symptoms and functional status, recurrence or relapse, and satisfaction with and adverse effects of treatment. Outcomes were assessed by telephone interview at days 3, 7, 10, and 28.

Results A total of 166 adults (36% male; 78% with white race) were randomized to amoxicillin (n = 85) or placebo (n = 81); 92% concurrently used 1 or more symptomatic treatments (94% for amoxicillin group vs 90% for control group; P = .34). The mean change in Sinonasal Outcome Test-16 scores was not significantly different between groups on day 3 (decrease of 0.59 in the amoxicillin group and 0.54 in the control group; mean difference between groups of 0.03 [95% CI, −0.12 to 0.19]) and on day 10 (mean difference between groups of 0.01 [95% CI, −0.13 to 0.15]), but differed at day 7 favoring amoxicillin (mean difference between groups of 0.19 [95% CI, 0.024 to 0.35]). There was no statistically significant difference in reported symptom improvement at day 3 (37% for amoxicillin group vs 34% for control group; P = .67) or at day 10 (78% vs 80%, respectively; P = .71), whereas at day 7 more participants treated with amoxicillin reported symptom improvement (74% vs 56%, respectively; P = .02). No between-group differences were found for any other secondary outcomes. No serious adverse events occurred.

Conclusion Among patients with acute rhinosinusitis, a 10-day course of amoxicillin compared with placebo did not reduce symptoms at day 3 of treatment.

13. Omental Infarction: Case Series and Review of the Literature

Park TU, et al. J Emerg Med. 2012;42:149-154.

Background: Omental infarction is a rare disease entity that can cause acute or subacute abdominal pain. In the past, it was thought that omental infarction mainly occurred on the right side because it was detected when surgery was performed on patients who complained of abdominal pain on the right side.

Objective: We present this case to demonstrate that omental infarction can occur at any site, including the epigastric area and the lower abdomen, and even on the left side where the greater omentum is located.

Case Report: Four patients with omental infarction presented to the Emergency Department with various clinical symptoms. All of them were diagnosed by computed tomography scan. Omental infarction occurred on the right side in 2 patients, at the epigastric area in 1 patient, and on the left side in 1 patient. Three were improved with supportive care. Laparoscopy was performed in 1 patient because his abdominal pain persisted despite conservative treatment.

Conclusion: Omental infarction should be included in the differential diagnosis list of acute abdominal pain because it can occur at any site. In addition, because this disease runs a self-limited course, conservative care is recommended. Thus, unnecessary operations can be avoided in cases where omental infarction is diagnosed by imaging studies.

14. Rates of Positive Blood, Urine, and CSF Cultures in Children Younger Than 60 Days during the Vaccination Era

Morley EJ, et al. Pedatr Emerg Care 2012;28:125-130.

Background: Fever is a common reason children present to the emergency department. The goal of this study was to determine the rates and the etiology of bacterial infection in children younger than 2 months during the vaccination era.

Methods: This is a retrospective chart review performed at a tertiary care hospital. Electronic medical records were used to identify patients who had a workup for fever/sepsis in the emergency department. The search was limited to identifying only children younger than 60 days.

Results: A total of 207 patients satisfied the inclusion/exclusion criteria. In children younger than 28 days, the blood culture–positive rate was 2.7% (range, 0.0%–6.4%), the urine culture–positive rate was 10.7% (range, 3.5%–17.8%), and the cerebrospinal fluid–positive rate (excluding enteroviral infections) was 0% (range, 0.0%–3.9%). In children 29 to 60 days, the blood culture–positive rate was 1.5% (range, 0.0%–3.6%), urine culture–positive rate was 8.5% (range, 3.7%–13.3%), and the cerebrospinal fluid–positive rate (excluding enteroviral infections) was 1.7% (range, 0.0%–5.0%). Urinary tract infections due to Escherichia coli were very common, whereas no cases of Haemophilus influenzae and one case of Streptococcus pneumoniae were detected.

Conclusions: Urinary tract infections due to E. coli are very common in this age group. The classic pathogens H. influenzae and S. pneumoniae were essentially nonexistent in this study possibly because of herd immunity obtained through current vaccination practices.

15. What’s New? Exuberance for Novelty Has Benefits

By JOHN TIERNEY. New York Times. Published: February 13, 2012

Do you make decisions quickly based on incomplete information? Do you lose your temper quickly? Are you easily bored? Do you thrive in conditions that seem chaotic to others, or do you like everything well organized?

Those are the kinds of questions used to measure novelty-seeking, a personality trait long associated with trouble. As researchers analyzed its genetic roots and relations to the brain’s dopamine system, they linked this trait with problems like attention deficit disorder, compulsive spending and gambling, alcoholism, drug abuse and criminal behavior.

Now, though, after extensively tracking novelty-seekers, researchers are seeing the upside. In the right combination with other traits, it’s a crucial predictor of well-being…

The remainder of the article: http://www.nytimes.com/2012/02/14/science/novelty-seeking-neophilia-can-be-a-predictor-of-well-being.html

16. Value of a rigid collar in addition to head blocks may be unnecessary

Holla M. Emerg Med J 2012;29:104-107.

Background All trauma patients with a cervical spinal column injury or with a mechanism of injury with the potential to cause cervical spinal injury should be immobilised until a spinal injury is excluded. Immobilisation of the entire patient with a rigid cervical collar, backboard, head blocks with tape or straps is recommended by the Advanced Trauma Life Support guidelines. However there is insufficient evidence to support these guidelines.

Objective To analyse the effects on the range of motion of the addition of a rigid collar to head blocks strapped on a backboard.

Method The active range of motion of the cervical spine was determined by computerised digital dual inclinometry, in 10 healthy volunteers with a rigid collar, head blocks strapped on a padded spine board and a combination of both. Maximal opening of the mouth with all types of immobiliser in place was also measured.

Results The addition of a rigid collar to head blocks strapped on a spine board did not result in extra immobilisation of the cervical spine. Opening of the mouth was significantly reduced in patients with a rigid collar.

Conclusion Based on this proof of principle study and other previous evidence of adverse effects of rigid collars, the addition of a rigid collar to head blocks is considered unnecessary and potentially dangerous. Therefore the use of this combination of cervical spine immobilisers must be reconsidered.

17. Reversal of warfarin-induced hemorrhage in the ED

Zareh M, et al. West J Emerg Med. 2011 Nov;12(4):386-92.

Warfarin, an oral vitamin K antagonist, is used to prevent arterial and venous thromboembolism in patients suffering from a multitude of diseases. In 2004, 31 million warfarin prescriptions were dispensed in the United States. Warfarin inhibits the activation of the vitamin K-dependent clotting factors (Factors II, VII, IX, and X) and regulatory proteins (proteins C, S, and Z). It is one of the leading drugs implicated in emergency room visits for adverse drug reactions. Annually the frequency of bleeding complications associated with overanticoagulation is 15% to 20%, with fatal bleeds measuring as high as 1% to 3%.

The most effective method of warfarin reversal involves the use of Four Factor Prothrombin Complex Concentrate (PCC), which is widely used throughout Europe but is unavailable in the United States. The current therapies available to emergency room physicians in the United States are fresh frozen plasma, recombinant Factor VIIa (rFVIIa), Factor Eight Inhibitory Bypassing Activity, or Three Factor PCC concomitantly administered with vitamin K. We review the advantages and disadvantages of these therapies and recommend Three Factor PCC with small doses of rFVIIa and with vitamin K in life-threatening situations if Four Factor PCC is unavailable.

Full-text (free): http://www.escholarship.org/uc/item/12f3z5c9#page-1

18. Images in Clinical Medicine

Post-Traumatic Herniated Cervical Disk
http://www.nejm.org/doi/full/10.1056/NEJMicm1111194

Deep Sulcus Sign
http://www.nejm.org/doi/full/10.1056/NEJMicm1105315

Pyogenic Granuloma of the Finger
http://www.nejm.org/doi/full/10.1056/NEJMicm1107409

‘Where am I?’ – An unusual stroke presentation
http://casereports.bmj.com/content/2012/bcr.12.2011.5296.full

Vernal Keratoconjunctivitis
http://www.nejm.org/doi/full/10.1056/NEJMicm1014624

Lingual Raynaud’s Phenomenon
http://www.nejm.org/doi/full/10.1056/NEJMicm1104140

Facial Swelling
http://www.annemergmed.com/article/S0196-0644(11)00715-3/fulltext

A Case of a Painful Swollen Leg
http://www.annemergmed.com/article/S0196-0644(11)00654-8/fulltext

19. Managing ED Patients with Recent-onset A Fib/Flutter: Cardioversion Safe and Effective

Vinson DR, et al. J Emerg Med. 2012;42(2):139-148.

BACKGROUND: The management of emergency department (ED) patients with presumed recent-onset atrial fibrillation or flutter less than 48h in duration varies widely.

OBJECTIVE AND METHOD: We conducted a prospective study across three affiliated community EDs within a large integrated health care delivery system to describe the management of patients with recent-onset atrial fibrillation or flutter, to determine the safety and effectiveness of ED cardioversion, and to measure the incidence of thromboembolism 30 days after discharge.

RESULTS: We enrolled 206 patients with convenience sampling between June 2005 and November 2007. Mean age was 64.0+/-14.4 years (range 21-96 years). Patients were grouped for analysis into four categories based on whether cardioversion was 1) spontaneous in the ED (59; 28.6%); 2) attempted with electrical or pharmacological means (115; 56.3%), with success in 110 (95.7%); 3) hoped for during a short stint of home observation (16; 7.8%, 11 of which spontaneously converted to sinus rhythm within 24h); or 4) contraindicated (16; 7.8%). Of the entire group, 183 (88.8%) patients were discharged home. Adverse events requiring ED interventions were reported in 6 (2.9%; 95% confidence interval [CI] 1.1-6.2%) patients, all of whom recovered. Two (1.0%; 95% CI 0.1-3.5%) patients were found to have an embolic event on 30-day follow-up.

CONCLUSIONS: Our approach to ED patients with presumed recent-onset atrial fibrillation or flutter seems to be safe and effective, with a high rate of cardioversion and discharge to home coupled with a low ED adverse event and 30-day thromboembolic event rate.

20. The Sufficiency of EM Physician Documentation of AMA Encounters

Monico EP. Emergency Medicine 2011, 1:e106. doi: 10.4172/egm.1000e106

A great deal of ambiguity exists among emergency medicine (EM) physicians regarding how to document against medical advice (AMA) encounters in the emergency department (ED) setting. In our own institution this ambiguity surfaces as inconsistent and eclectic documentation of patients terminating their evaluation and/ or treatment prematurely. This ambiguity suggests (EM) residency programs fail to educate EM physicians-in-training in the area of AMA encounters and the importance of this emergency patient population in the context of the extant EM climate. The Open Access Initiative provides an ideal venue to distribute information and supports efforts to establish uniformity in the provision of certain aspects of EM care, such as documentation of AMA encounters.

Emergency department overcrowding, healthcare manpower shortages, and lack of healthcare access have created novel quality and safety challenges not previously examined in US healthcare systems. Patients who leave before the conclusion of diagnostic and treatment modalities represent a failure of emergency healthcare [1]. These visits are used as a marker of ED crowding and have indirectly been linked to delays in treatment, [2-4] higher complication rates, [5] and increased mortality [6]. As such, the proportion of these visits has been proposed by the Joint Commission and Centers for Medicare and Medicaid Services (CMS) as hospital quality indicators [7]. Patients who leave the EM AMA represent a subset of this population and carry the same increased risk of morbidity and mortality [8,9].

In 2003, CMS mandated that the documentation of refusal to treat should include proof that patients had “been informed of the risks and benefits of the examination or treatment, or of both” [10]. The extent to which emergency physicians are aware of documentation requirements memorializing AMA encounters has never been formally addressed in the EM literature. Heretofore, the AMA literature focused on the identification of at-risk populations and demonstrated that middleage, impoverished, poorly–insured, males make up the lion share of this population.

A retrospective, year-long audit of ED AMA-encounters was conducted at our own institution between January 1 and December 31, 2010. During that time, four-hundred-and-eighteen patients left the ED AMA. The audit revealed 22.0% of EM-physicians documented patient capacity; (b) 34.9% documented extent or limitations of the evaluation; (c) 34.4% documented patient understanding of the diagnosis; (d) 43.1% documented physician concerns; (e) 66.7% documented the risks and benefits of leaving prematurely; (f) 5.8% documented alternative treatment or diagnostic options; (g) 97.8% explicitly documented that the patient left AMA; (h) 11.2% documented an opportunity to ask questions, 73.2% documented a follow-up care plan, and 68.9% documented that discharge instructions were received. In summary, we found that EM physicians sufficiently documented that patients left the ED AMA, but faired poorly in documenting other aspects of the encounter.

Critiques may argue that clinical demands prevent achieving the level of documentation suggested in our audit or that documentation advice aligns itself more closely with legal manoeuvres than with medical practice. However, these assertions, historically, do not tip scales in their favour when compared to the weight of federal mandates, standard of care requirements or professional liability threats. It remains unclear whether electronic medical records will facilitate AMA documentation compliance or further complicate the issue.

An effective and efficient standardization of the ED AMA encounter needs to be established to comport with federal and national documentation requirement. Future efforts in this area will include educating providers on AMA encounters, quality and safety risks, measuring the sufficiency of information received after this education, and comparing patient outcomes before and after these interventions.

Further multi-center studies are required to determine the extent of the problem, ascertain regional variations and attempt to uncover commonalities. If our audit forecasts the nature of AMA documentation in the U.S., these results demonstrate that physicians are not conducting AMA encounters according to quality and safety domains set forth by oversight institutions. Without appropriate documentation, it may be assumed that patients are ill-informed when deciding to leave the ED AMA.

Healthcare institutions should be cognisant of disparities between AMA documentation requirements enforced by oversight agencies and the documentation practices of EM physicians in their institution. Conformation to these requirements begins with the threshold determination of the sufficiency of extant documentation practices.

References (and full-text, free): http://omicsgroup.org/journals/EGM/EGM-1-e106.php

21. By the Sword: The Science (and Medical Complications) of Sword-Swallowing

By Jennifer Ouellette January 25, 2012 Scientific American

For all its long history, very few published reports exist of related injuries from the practice of shoving sharp steel blades down one’s throat — perhaps because there are only a little more than 100 sword swallowers worldwide, out of a population of some 6.6 billion people. That’s why Witcombe and Meyer set out to explore the various techniques and side effects of sword swallowing.

Forty-six Sword Swallowers Association International members participated in the study, having swallowed a combined 2000 swords over the prior three months. More than half (25) had swallowed more than one, five managed to swallow at least ten swords at a time, and one person achieved the whopping feat of swallowing 16 swords simultaneously.

A news release last December reported that Witcombe and Meyer found, “Sword swallowers are more likely to sustain an injury — such as a perforation of the esophagus — if they are distracted or are using multiple or unusual swords.”

Mostly, the respondents suffered from a sore throat (or as they call it, “sword throat,” such wags, those guys), generally from the multiple sword stunts, or swallowing odd-shaped blades such as curved sabers rather than straight ones. Lower chest pains were another common complaint — the only remedy being not swallowing any swords for a few days.

Sixteen had suffered some form of intestinal bleeding, and three had undergone surgery to repair injuries to their necks. One lacerated his pharynx, another slashed his esophagus — he claimed to have been distracted by a misbehaving macaw on his shoulder — and one unfortunate belly dancer suffered a major hemorrhage when three blades lodged in her esophagus unexpectedly “scissored,” after an appreciative bystander shoved some dollar bills in her belt. His donation didn’t come close to covering her medical expenses, which came close to $70,000. Not surprisingly, most sword swallowers have higher than average health care and medical costs. All it takes it one tiny slip-up, after all.

These injuries are quite real, and quite serious, because unlike many other sideshow novelty acts, sword swallowing is not a magician’s illusion — although there is a trick to it (more on that later). As the x-ray image above attests, sword swallowers really do maneuver that sharp metal blade down the hatch, past all kinds of vital organs…

The complete article (free): http://blogs.scientificamerican.com/cocktail-party-physics/2012/01/25/by-the-sword-the-science-of-sword-swallowing/